Maria V. Dieci
Padova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 204 publications
Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers.
Journal: JAMA network open
Published: August 26, 2026
Advancing breast cancer clinical management through technological innovation: the potential role of artificial intelligence and integrated care models.
Journal: ESMO open
Published: April 30, 2026
Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.
Journal: Journal of the National Cancer Institute
Published: April 17, 2026
Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 16, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.
Journal: Nature communications
Published: April 15, 2026
Evolution of ER-cut-off definition in clinical trials for triple negative breast cancer: trends and patterns over 15 years.
Journal: Breast (Edinburgh, Scotland)
Published: March 25, 2026
Tumor infiltrating lymphocytes as a predictor of adjuvant avelumab efficacy in patients with high-risk triple negative breast cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 11, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 08, 2026
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 08, 2026
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study.
Journal: Breast (Edinburgh, Scotland)
Published: December 22, 2025
Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
Journal: The Lancet. Oncology
Published: November 17, 2025
Last Updated: 09/26/2026